Gian Marco De Marchis1, Deborah Pugin1, Emma Meyers1, Angela Velasquez1, Sureerat Suwatcharangkoon1, Soojin Park1, M Cristina Falo1, Sachin Agarwal1, Stephan Mayer1, J Michael Schmidt1, E Sander Connolly1, Jan Claassen2. 1. From the Department of Neurology (G.M.D.M., D.P., E.M., A.V., S.S., S.P., M.C.F., S.A., S.M., J.M.S., E.S.C., J.C.), Division of Neurocritical Care, College of Physicians and Surgeons, Columbia University, New York, NY; the Department of Neurology (G.M.D.M.), University Hospital Basel, Switzerland; and the Department of Medicine, Division of Neurology (S.S.), Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. 2. From the Department of Neurology (G.M.D.M., D.P., E.M., A.V., S.S., S.P., M.C.F., S.A., S.M., J.M.S., E.S.C., J.C.), Division of Neurocritical Care, College of Physicians and Surgeons, Columbia University, New York, NY; the Department of Neurology (G.M.D.M.), University Hospital Basel, Switzerland; and the Department of Medicine, Division of Neurology (S.S.), Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. jc1439@mail.cumc.columbia.edu.
Abstract
OBJECTIVE: To assess the relationship between seizure burden on continuous EEG (cEEG) and functional as well as cognitive outcome 3 months after subarachnoid hemorrhage (SAH). METHODS: The study included all consecutive patients with a spontaneous SAH admitted to the Columbia University Medical Center Neurological Intensive Care Unit and monitored with cEEG between 1996 and 2013. Seizure burden was defined as the duration, in hours, of seizures on cEEG. Cognitive outcomes were measured with the Telephone Interview for Cognitive Status (TICS, ranging from 0 to 51, indicating poor to good global mental status). RESULTS: Overall, 402 patients with SAH were included with a median age of 58 years (interquartile range [IQR] 46-68 years). The median duration of cEEG monitoring was 96 hours (IQR 48-155 hours). Seizures were recorded in 50 patients (12%), in whom the median seizure burden was 6 hours (IQR 1-13 hours). At 3 months, in multivariate analysis, seizure burden was associated with unfavorable functional and cognitive outcome. Every hour of seizure on cEEG was associated with an odds ratio of 1.10 (95% confidence interval [CI] 1.01-1.21, p = 0.04) to 3-month disability and mortality, and the TICS-score decreased, on average, by 0.16 points (adjusted coefficient -0.19, 95% CI -0.33 to -0.05, p = 0.01). CONCLUSION: In this study, after adjusting for established predictors, seizure burden was associated with functional outcome and cognitive impairment 3 months after SAH.
OBJECTIVE: To assess the relationship between seizure burden on continuous EEG (cEEG) and functional as well as cognitive outcome 3 months after subarachnoid hemorrhage (SAH). METHODS: The study included all consecutive patients with a spontaneous SAH admitted to the Columbia University Medical Center Neurological Intensive Care Unit and monitored with cEEG between 1996 and 2013. Seizure burden was defined as the duration, in hours, of seizures on cEEG. Cognitive outcomes were measured with the Telephone Interview for Cognitive Status (TICS, ranging from 0 to 51, indicating poor to good global mental status). RESULTS: Overall, 402 patients with SAH were included with a median age of 58 years (interquartile range [IQR] 46-68 years). The median duration of cEEG monitoring was 96 hours (IQR 48-155 hours). Seizures were recorded in 50 patients (12%), in whom the median seizure burden was 6 hours (IQR 1-13 hours). At 3 months, in multivariate analysis, seizure burden was associated with unfavorable functional and cognitive outcome. Every hour of seizure on cEEG was associated with an odds ratio of 1.10 (95% confidence interval [CI] 1.01-1.21, p = 0.04) to 3-month disability and mortality, and the TICS-score decreased, on average, by 0.16 points (adjusted coefficient -0.19, 95% CI -0.33 to -0.05, p = 0.01). CONCLUSION: In this study, after adjusting for established predictors, seizure burden was associated with functional outcome and cognitive impairment 3 months after SAH.
Authors: S A Mayer; K T Kreiter; D Copeland; G L Bernardini; J E Bates; S Peery; J Claassen; Y E Du; E S Connolly Journal: Neurology Date: 2002-12-10 Impact factor: 9.910
Authors: Lyle J Dennis; Jan Claassen; Lawrence J Hirsch; Ronald G Emerson; E Sander Connolly; Stephan A Mayer Journal: Neurosurgery Date: 2002-11 Impact factor: 4.654
Authors: A R Towne; E J Waterhouse; J G Boggs; L K Garnett; A J Brown; J R Smith; R J DeLorenzo Journal: Neurology Date: 2000-01-25 Impact factor: 9.910
Authors: J Claassen; G L Bernardini; K Kreiter; J Bates; Y E Du; D Copeland; E S Connolly; S A Mayer Journal: Stroke Date: 2001-09 Impact factor: 7.914
Authors: P M Vespa; K O'Phelan; M Shah; J Mirabelli; S Starkman; C Kidwell; J Saver; M R Nuwer; J G Frazee; D A McArthur; N A Martin Journal: Neurology Date: 2003-05-13 Impact factor: 9.910
Authors: Sahar F Zafar; Edilberto Amorim; Craig A Williamsom; Jin Jing; Emily J Gilmore; Hiba A Haider; Christa Swisher; Aaron Struck; Eric S Rosenthal; Marcus Ng; Sarah Schmitt; Jong W Lee; M Brandon Westover Journal: Clin Neurophysiol Date: 2020-06-24 Impact factor: 3.708
Authors: Mallika Purandare; Alexa N Ehlert; Henri Vaitkevicius; Barbara A Dworetzky; Jong Woo Lee Journal: Seizure Date: 2018-08-15 Impact factor: 3.184